209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors

Samuel J. Klempner, M. Beeram, Dhanusha Sabanathan, Anthony W.H. Chan, Erika Hamilton, Sherene Loi, D-Y. Oh, Leisha A. Emens, Amita Patnaik, J.E. Kim, Y.H. Park, Valerie Odegard, Sue Hamke, Geundoo Jang, Céline Jacquemont, Naomi Hunder, Sarina A. Piha‐Paul